| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Department of Pediatrics, Karolinska Institute, Huddinge University Hospital (A.N., A.L.), S-141 86 Stockholm, Sweden; Department of Psychology, University of Uppsala (A.S., G.B.), S-751 42 Uppsala, Sweden; and Department of Molecular Medicine, Karolinska Institute, Karolinska Hospital (A.W.), S-171 76 Stockholm, Sweden
Address all correspondence and requests for reprints to: Dr. Anna Nordenström, Department of Pediatrics, Karolinska Institute, Huddinge University Hospital, S-141 86 Stockholm, Sweden. E-mail: anna.nordenstrom{at}klinvet.ki.se.
Abstract
Previous studies have shown that girls with congenital adrenal hyperplasia (CAH), a syndrome resulting in overproduction of adrenal androgens from early fetal life, are behaviorally masculinized. We studied play with toys in a structured play situation and correlated the results with disease severity, assessed by CYP21 genotyping, and age at diagnosis. Girls with CAH played more with masculine toys than controls when playing alone. In addition, we could demonstrate a dose-response relationship between disease severity (i.e. degree of fetal androgen exposure) and degree of masculinization of behavior. The presence of a parent did not influence the CAH girls to play in a more masculine fashion. Four CAH girls with late diagnosis are also described. Three of the four girls played exclusively with one of the masculine toys, a constructional toy. Our results support the view that prenatal androgen exposure has a direct organizational effect on the human brain to determine certain aspects of sex-typed behavior.
BEHAVIORAL STUDIES in children with congenital adrenal hyperplasia (CAH) are important for several reasons. They provide information that is important for the management and follow-up of patients. In addition, the influence of prenatal and neonatal hormonal factors on sex differences in behavior can be studied in girls with CAH, as these children have been exposed to elevated levels of androgens from early fetal development.
In the 1960s, Money and Ehrhardt (1) reported that girls with CAH often preferred boys toys and outdoor sports. Since then, several studies have shown that girls with CAH are behaviorally masculinized (2, 3, 4). Girls with CAH reached higher scores than their sisters in some cognitive parameters, such as three-dimensional rotational spatial ability, a pattern similar to that seen in comparisons of normal boys and girls (5, 6). Women with CAH showed a typical male pattern for measures of personality traits (7). In direct observational studies of toy play Berenbaum et al. (8, 9) showed that girls with CAH played more with boys toys and less with girls toys than their unaffected sisters. The results regarding the correlation of disease severity with degree of masculinization of behavior have been somewhat contradictory (2, 3, 8, 10). Berenbaum et al. (11) and our group (Servin, A., A. Nordenström, A. Larsson, and G. Bohlin, submitted for publication) have shown that childhood boy-typical interest was strongly associated with the degree of virilization of the genitalia, an indicator of prenatal androgen exposure. It has been argued that the behavioral changes in girls with CAH are the results of the parental treatment triggered by the virilization of genitalia at birth (13). On the other hand, the persistence of sex-atypical interests, activities, and careers in adolescent girls with CAH suggests that they result from the direct effects of androgens on the developing brain rather than social responses, because these girls were brought up as females (14). The vast majority of girls with CAH have a typical female gender identity (15).
CAH constitutes a family of defects in the synthesis of steroid hormones in the adrenal cortex. In more than 90% of the cases it is caused by a defect in the 21-hydroxylase gene (CYP21) (16, 17). The enzyme deficiency results in impaired synthesis of cortisol and aldosterone. The low cortisol level results in increased production of ACTH by the pituitary, which causes hyperplasia of the adrenal glands and increased synthesis of steroid precursors, resulting in high androgen levels. The androgen excess is present from early embryogenesis and results in varying degrees of virilization of the external genitalia in girls depending on the degree of enzyme deficiency. In severe forms, the virilization may result in uncertainty in gender assignment at birth, and the sex of some girls is initially designated as male.
The molecular genetics of 21-hydroxylase deficiency have been studied extensively. More than 95% of the patients are homozygous or compound heterozygotes for any of nine different point mutations or deletion of the CYP21 gene. With very few exceptions there is a good correlation between the CYP21 genotype and disease severity (18, 19, 20). Deletions or mutations that completely abolish enzyme activity are referred to as null mutations. Patients who are homozygous for null mutations have the most severe form of the disease, with salt loss in the neonatal period and severe prenatal virilization of external genitalia in girls. The I2 splice mutation is slightly less severe; some homozygous patients are not affected by salt loss. The I172N mutation is associated with varying degrees of virilization of external genitalia, but only about 10% of patients with this genotype show signs of salt loss. The V281L mutation is even milder and is associated with nonclassical CAH without virilization of external genitalia at birth. Untreated, these patients develop symptoms of androgen excess later in life, such as accelerated growth rate, hirsutism, or infertility. At birth, most children with CAH are diagnosed either because of clinical signs or in neonatal screening programs. The treatment consists of glucocorticoid and mineralocorticoid substitution that decreases/normalizes ACTH levels and thereby androgen production. Corrective surgery on the external genitalia is performed when needed (17).
In this study we wanted to investigate further the possible influence of disease severity, i.e. the degree of fetal androgen exposure, on toy play and toy preference in girls with CAH. For this purpose we took advantage of the possibility of determining the degree of 21-hydroxylase deficiency by CYP21 genotyping. There is a good genotype-phenotype correlation (18, 19, 20), and genotyping is also a more objective way to measure disease severity compared with other methods, such as Prader score or classification according to salt loss. Furthermore, we have previously shown that at birth the level of one of the hormones preceding the enzyme block, 17-hydroxyprogesterone, is correlated to the CYP21 genotype (21). This indicates that the androgen level, to which the fetus is exposed, during intrauterine life is related to the genotype. We measured sex-typed play behavior in a structured play situation. To assess parental influence, toy play was studied when the child was playing alone as well as when a parent was present. A possible influence of postnatal androgen exposure on toy preference was studied in four children with late diagnosis who had been untreated until 36 yr of age.
Subjects and Methods
Study population
All families in Sweden with girls with CAH between 1 and 10 yr of age were contacted during 19972000 and asked to participate. Five families did not agree to participate. A total of 40 girls with CAH in 35 families were included in the study. CYP21 mutation analysis was performed in 39 of these children. The 4 girls who had been diagnosed prenatally and treated with dexamethasone in utero until term were excluded from this study. Four girls had been missed by the screening and were diagnosed late, at 36 yr of age. Healthy girls matched for age ±2 months on a case by case basis were used as controls.
Mutation analysis
CYP21 mutation analysis was carried out using allele-specific PCR from genomic DNA prepared from venous blood samples (22). This detects the 95% of alleles that carry any of the common pseudogene-derived mutations. Additional rare alleles were characterized by direct DNA sequencing (23). The genotypes were divided into four groups with respect to the severity of the mutation of the allele with the mildest mutation: null, I2 splice, I172N, and V281L (see Tables 1
and 2
). We were able to obtain a sample for CYP21 mutation analysis from all but one child.
|
|
In a structured toy play situation, 10 different toys that had previously been defined as masculine, feminine, or neutral for children in the presently employed ages were used (9, 24, 25, 26, 27). Feminine toys included a doll with a blanket and feeding bottle, Barbie and Ken dolls, a teapot with four cups, and a female dolls head with brush, comb, and mirror. Masculine toys were a bus, a garage with four cars, a constructional toy (Lincoln logs), and two fighting figures. Neutral toys were a sketchbook and a deck of cards. The toys were arranged in a standard order in a semicircle on the floor in the homes of the children, with every other toy being masculine and feminine and the neutral toys in between. The child was asked to sit in the middle of the semicircle and was videotaped for 7 min when playing alone and for 7 min when playing with her parent. The play order, alone vs. with a parent, was alternated. The families with a girl with CAH could choose whether the mother or the father would participate (two fathers participated). The control families were matched for these factors. The tapes were then scored for the number of seconds that the child played with the different types of toys. Play was defined as the child touching the toy. The person who scored the tapes was blind to the status of the child on the tape. At the end of the visit the children were given a toy to keep as a present. They were able to choose between a doll (feminine), a car (masculine), and a ball (neutral).
Statistical analysis
The girls with CAH, regardless of disease severity, and the controls were compared with respect to toy play using the Mann-Whitney U test. The relationship between toy play and genotype was analyzed by means of the Spearman rank order correlation coefficient. The groups were graded according to enzyme activity, with the null genotype group being the lowest and the controls the highest. The girls with late diagnosis were compared with respect to toy play with other girls of the same age, both controls and girls with CAH and early diagnosis, using the Kruskal-Wallis and Mann-Whitney U tests. Intraindividual comparison of toy play with and without a parent was analyzed using Wilcoxons signed ranks test. Fishers exact test was used to compare the choice of toy to keep as a present. The choice of doll vs. one of the other toys and the choice of car vs. one of the other toys was tested for the CAH girls with early diagnosis (as a group) compared with the controls. The choice of doll vs. one of the other toys was tested for the CAH girls with late diagnosis compared with girls with CAH and early diagnosis of the same age as well as with girls with the same mutations and early diagnosis regardless of age. SPSS computer program 10.1 (SPSS, Inc., Chicago, IL) was used for all the statistical analyses. The
level was set at 0.05.
The study was approved by the ethical committee of the Karolinska Institute (Stockholm, Sweden). Informed consent was obtained from all participants.
Results
The 31 girls with early diagnosis and start of treatment in the neonatal period were divided into 4 genotype groups (Table 1
). Three of the groups were of equal size, and 1 was smaller, comprising only 3 children. The mean Prader scores for the different genotype groups are also listed in Table 1
. In addition, there were 4 girls with late diagnosis and treatment (Table 2
). Two of them belonged to the I172N genotype group and had started treatment at 3 yr of age. The other 2 belonged to the V281L genotype group and had been treated since 6 yr of age (Table 2
).
We compared toy play for CAH and control girls when the children were playing alone. As expected, there was a significant difference in toy play for masculine toys between the girls with CAH as a group and the controls (P = 0.017). In addition, we found a significant correlation between the degree of disease severity as measured by CYP21 genotypes and the amount of time the CAH girls spent playing with masculine toys (r = -0.39; P = 0.002; Fig. 1A
). The correlation was also significant when the controls were excluded (r = -0.41; P = 0.024). For play with neutral toys the correlation was significant, but less striking (r = 0.27; P = 0.036), and the coefficient when the controls were excluded was r = 0.34; P = 0.064 (Fig. 1C
). The correlation was not significant for play with the feminine toys (Fig. 1B
; r = 0.20; P = 0.129 with the controls included and r = 0.12; P = 0.53 with the controls excluded from the calculation). In conclusion, the milder the disease, i.e. the higher the enzyme activity and therefore the lower the androgen level, the less time was spent with the masculine toys, whereas neutral toys were increasingly preferred. As shown in Fig. 1
, the girls with CAH in all of the genotype groups played more with the masculine than with the feminine or neutral toys. The control girls also played more with the masculine toys than with the feminine ones (Fig. 1
and Table 1
).
|
|
|
Discussion
We found that girls with CAH played more with masculine toys than controls, which is in line with the findings of previous studies (9, 3, 28). In addition, this study is the first to correlate behavior to CYP21 genotype, which is known to reflect the degree of disease severity and thus the degree of fetal androgen exposure. We found a dose-response relationship between disease severity (i.e. degree of fetal androgen exposure) and degree of masculinization of toy play and preference. This finding supports a biological basis for the differences in play behavior between CAH girls and unaffected girls. It has been argued that the masculinization of play behavior that has been seen in girls with CAH can be attributed to parental influence due to expectations of a more masculine behavior in these girls triggered by the virilization of external genitalia at birth (13). Our results do not support this view. When a parent was present, there was no difference in toy play for the girls with the most severe form of CAH, and the girls with less severe forms of CAH played less, rather than more, with masculine toys.
The possible effects of prenatal vs. postnatal androgen exposure on behavior have been discussed. Hormones are considered to affect behavior in different ways (29), namely by having an early organizational effect that takes place during certain critical periods of development and/or a later activational effect, for instance during puberty. Maze learning in rodents, for example, is dependent on organizational influences of androgens (29). In this study the results in girls with CAH diagnosed and treated at an early age favor a prenatal, organizational effect of androgens during the development of the central nervous system. On the other hand, even though there are few observations, our results for the girls with CAH diagnosed late indicate that postnatal androgens may have effects as well. The girls with late diagnosis all had less severe forms of CAH and can be assumed to have been exposed to lower levels of androgens in utero. They were diagnosed at 3 or 6 yr of age and therefore had an overproduction of androgens during the first years of life. Three of these girls played with the Lincoln logs the whole time when they played alone. This result was significantly different from the result for the controls in the same age group. In addition, there was a statistical trend that the girls with late diagnosis played more with the constructional toy compared with CAH girls of the same age but with early diagnosis (P = 0.1). These results are intriguing because they contrast with the results in the choice of toy to keep as a present. It was striking that 3 of the CAH girls with late diagnosis preferred the doll, and only 1 chose the ball to keep, while among the girls with the same mutations, I172N or V281L, and early diagnosis 2 of 12 chose a doll. This raises questions concerning the possibility that prenatal and postnatal androgen exposure may affect different aspects of cognitive development.
In a study by Berenbaum et al. (11) a much less marked effect of postnatal than prenatal androgen exposure in masculinizing play behavior was shown. This is in agreement with the results of our studies. However, in their study the effect on spatial ability or play with constructional toys was not studied specifically. The possibility of a postnatal effect of androgens on central nervous system development has implications for treatment during the first years of life. It has been argued that the glucocorticoid dose should be kept low during the first 12 yr to minimize the negative effects on growth, as no effect of androgens on growth or skeletal maturation has been observed during this period (30). However, if elevated androgen levels have an effect on the developing brain, perhaps this regimen should only be used in boys with CAH.
We recognize that additional factors, such as upbringing and cultural influences, play vital roles in such complex human characteristics as behavior. We believe, however, that girls with CAH will benefit from an increased understanding and acceptance of their preferences as well as from the acknowledgment that parental expectations, if anything, tend to counteract them.
In conclusion, we have found evidence supporting the idea that prenatal androgen exposure has a direct organizational effect on the human brain so as to determine certain aspects of sex-typed behavior. In addition, our data raise questions concerning possible postnatal effects of androgens. Further studies are needed on this subject to clarify the possible sensitive periods and levels of androgens mediating these effects.
Acknowledgments
We gratefully acknowledge Sheri Berenbaum for her valuable contribution in planning this study. We are grateful to the children and their families for their cooperation.
Footnotes
This work was supported by the Swedish Medical Research Council, Grants 4792 and 12198, the Novo Nordisk Foundation, the Märta and Gunnar Philipson Foundation, the Samariten Foundation, and the Frimurare Barnhuset Foundation.
Abbreviation: CAH, Congenital adrenal hyperplasia.
Received September 21, 2001.
Accepted July 30, 2002.
References
This article has been cited by other articles:
![]() |
L. Frisen, A. Nordenstrom, H. Falhammar, H. Filipsson, G. Holmdahl, P. O. Janson, M. Thoren, K. Hagenfeldt, A. Moller, and A. Nordenskjold Gender Role Behavior, Sexuality, and Psychosocial Adaptation in Women with Congenital Adrenal Hyperplasia due to CYP21A2 Deficiency J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3432 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ciumas, A. L. Hirschberg, and I. Savic High Fetal Testosterone and Sexually Dimorphic Cerebral Networks in Females Cereb Cortex, May 1, 2009; 19(5): 1167 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zethraeus, L. Kocoska-Maras, T. Ellingsen, B. von Schoultz, A. L. Hirschberg, and M. Johannesson A randomized trial of the effect of estrogen and testosterone on economic behavior PNAS, April 21, 2009; 106(16): 6535 - 6538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Knickmeyer and S. Baron-Cohen Topical Review: Fetal Testosterone and Sex Differences in Typical Social Development and in Autism J Child Neurol, October 1, 2006; 21(10): 825 - 845. [Abstract] [PDF] |
||||
![]() |
C. P. Houk, I. A. Hughes, S. F. Ahmed, P. A. Lee, and Writing Committee for the International Intersex C Summary of Consensus Statement on Intersex Disorders and Their Management Pediatrics, August 1, 2006; 118(2): 753 - 757. [Full Text] [PDF] |
||||
![]() |
P. A. Lee, C. P. Houk, S. F. Ahmed, I. A. Hughes, and in collaboration with the participants in the Inte Consensus Statement on Management of Intersex Disorders Pediatrics, August 1, 2006; 118(2): e488 - e500. [Full Text] [PDF] |
||||
![]() |
I A Hughes, C Houk, S F Ahmed, P A Lee, and LWPES/ESPE Consensus Group Consensus statement on management of intersex disorders Arch. Dis. Child., July 1, 2006; 91(7): 554 - 563. [Full Text] [PDF] |
||||
![]() |
C. M. Hall, J. A. Jones, H. F. L. Meyer-Bahlburg, C. Dolezal, M. Coleman, P. Foster, D. A. Price, and P. E. Clayton Behavioral and Physical Masculinization Are Related to Genotype in Girls with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pinto, V. Tardy, C. Trivin, C. Thalassinos, S. Lortat-Jacob, C. Nihoul-Fekete, Y. Morel, and R. Brauner Follow-Up of 68 Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Relevance of Genotype for Management J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2624 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Sherwin Estrogen and Cognitive Functioning in Women Endocr. Rev., April 1, 2003; 24(2): 133 - 151. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |